# Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting

> **NCT01405248** · PHASE3 · COMPLETED · sponsor: **Jinling Hospital, China** · enrollment: 100 (actual)

## Conditions studied

- Restenosis

## Interventions

- **DRUG:** Butylphthalide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01405248
- **Lead sponsor:** Jinling Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2015-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01405248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01405248, "Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01405248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*